Phase II/III study in children and adolescents with newly diagnosed B-cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan

B-cell precursor acute lymphoblastic leukemia is the most common pediatric malignancy, but its treatment needs to be modified to cause low acute toxicity and few late complications with a high cure rate. In this trial, we will stratify patients with B-cell precursor acute lymphoblastic leukemia into...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Katsuyoshi, Kato, Motohiro, Saito, Akiko M, Kada, Akiko, Kawasaki, Hirohide, Okamoto, Yasuhiro, Imamura, Toshihiko, Horibe, Keizo, Manabe, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Clinical Trial Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022563/
https://www.ncbi.nlm.nih.gov/pubmed/29860341
http://dx.doi.org/10.1093/jjco/hyy071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022563/
https://www.ncbi.nlm.nih.gov/pubmed/29860341
http://dx.doi.org/10.1093/jjco/hyy071

Ejemplares similares